From prostate-specific antigen to precision: The future of prostate cancer diagnosis with artificial intelligence, biomarkers, and imaging

Background:. Prostate cancer (PCa) diagnosis has historically relied on prostate-specific antigen (PSA) testing. Although PSA screening significantly reduces mortality rates, it is limited by its low specificity and the risk of overdiagnosis and overtreatment. These limitations highlight the need fo...

Cijeli opis

Bibliografski detalji

Glavni autori:	Helena Margot Flôres Soares da Silva, Juan Gómez Rivas, Paula Mata Déniz, María Jesús Marugan, Claudia González-Santander, Lorena Fernández Montarroso, Isabel Galante, Jesús Moreno Sierra
Format:	Artigo
Jezik:	Inglês
Izdano:	Wolters Kluwer Health 2026-05-01
Serija:	Current Urology
Online pristup:	http://journals.lww.com/10.1097/CU9.0000000000000326
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!